C3.ai, Inc. (AI) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

After listening to the enterprise AI specialist's latest earnings call, I have some concerns over where the company is headed ...

Investors should always rely on their own analysis, not just management talk and projections, when deciding whether to buy a ...

The new iteration of C3 Pharmaceuticals, Inc. announced that it executed a tailored Share Subscription Agreement (SSA) with ...

C3.ai's growth is fairly modest given its size and the strength of the demand environment. Read why I remain neutral on AI ...

One of the biggest headwinds looming for C3.ai: whether Baker Hughes, its most important customer, extends its partnership in ...

We recently published a list of 10 AI News and Analyst Ratings You Should Not Miss. Since C3.ai Inc (NYSE:AI) ranks 10th on ...

Executives are fighting back against a federal court decision that banned them from the securities industry and ordered them ...

Let's review those challenges and see if it's the right time to buy or sell C3.ai's stock while it's still trading about 50% ...

This was the stock's fourth consecutive day of gains.

Enterprises and institutions are rushing to develop an AI strategy, which will be a tailwind for these two AI stocks.

We recently published a list of 10 AI News and Analyst Ratings You Should Not Miss. Since C3.ai Inc (NYSE:AI) ranks 10th on the list, it deserves a deeper look. While everyone is talking about ...